Filing Details
- Accession Number:
- 0001161697-21-000393
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-19 17:07:54
- Reporting Period:
- 2021-08-17
- Accepted Time:
- 2021-08-19 17:07:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402652 | Alicia Grande | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Vp, Treasurer And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2021-08-17 | 100,000 | $3.12 | 507,441 | No | 4 | M | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2021-08-17 | 100,000 | $5.67 | 407,441 | No | 4 | S | Direct | |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2021-08-18 | 70,000 | $3.12 | 477,441 | No | 4 | M | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2021-08-18 | 13,000 | $5.68 | 464,441 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options to purchase common stock | Disposition | 2021-08-17 | 100,000 | $0.00 | 100,000 | $3.12 |
Common Stock | Options to purchase common stock | Disposition | 2021-08-18 | 70,000 | $0.00 | 70,000 | $3.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,391,334 | 2021-08-28 | No | 4 | M | Direct | |
1,321,334 | 2021-08-28 | No | 4 | M | Direct |
Footnotes
- Shares were sold in various lots from $5.62 to $5.725 per share. The listed sale price represents a weightedaverage price for the shares sold.
- Shares were sold in various lots from $5.65 to $5.785 per share. The listed sale price represents a weighted average price for the shares sold.
- Shares were sold to cover exercise price of options and tax withholding requirements.
- Options vested in three annual tranches beginning on August 28, 2015.